Treatment strategy for certain advanced prostate cancers shows promise in preclinical models

Epigenetic changes can cause prostate cancer to resist treatment by switching genes on or off. One epigenetic mechanism tags genes with DNA methylation marks. This process is mediated by molecules called DNA methyltransferases. These tags can alter gene expression in ways that promote tumors to grow and transition into advanced forms of the disease.

Leave A Comment

Your email address will not be published. Required fields are marked *